Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.62 +0.01 (+0.61%)
As of: Sep 30, 2026 · 10:21 AM EDT

Chemomab Therapeutics (CMMB) Receivables - Other (2017 - 2018)

Updated

Chemomab Therapeutics' Receivables - Other came in at $21,000 for Q4 2018, up 40.0% from $15,000 a year earlier.

Analysis

Chemomab Therapeutics (CMMB) Receivables - Other (2017 - 2018) Analysis & Trends

  • Going back by year, Receivables - Other was $15,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Chemomab Therapeutics 11.80 Mn 11.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 21,000.00
Dec 31, 2017 15,000.00
API Access

Chemomab Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CMMB&period=max&api_key=YOUR_API_KEY